Online ISSN : 1347-5231
Print ISSN : 0031-6903
笹岡 沙也加畠平 春奈長谷川 栞元岡 佑美福田 昌穂長沼 美紗梅津 亮冴中尾 智史島内 あかり上田 夏実平出 耕石井口 和弘中村 光浩
ジャーナル フリー

2018 年 138 巻 1 号 p. 123-134


 OTC combination cold remedies are widely used in Japan. In the present study, we aimed to evaluate the adverse event profiles of OTC combination cold remedy based on the components using the Japanese Adverse Drug Event Report (JADER) database. The JADER database contained 430587 reports between April 2004 and November 2016. 1084 adverse events associated with the use of OTC combination cold remedy were reported. Reporting odds ratio (ROR) was used to detect safety signals. The ROR values for “skin and subcutaneous tissue disorders”, “hepatobiliary disorders”, and “immune system disorders” stratified by system organ class of the Medical Dictionary for Regulatory Activities (MedDRA) were 9.82 (8.71-11.06), 2.63 (2.25-3.07), and 3.13 (2.63-3.74), respectively. OTC combination cold remedy containing acetaminophen exhibited a significantly higher reporting ratio for “hepatobiliary disorders” than OTC combination cold remedy without acetaminophen. We demonstrated the potential risk of OTC combination cold remedy in a real-life setting. Our results suggested that the monitoring of individuals using OTC combination cold remedy is important.

© 2018 The Pharmaceutical Society of Japan
前の記事 次の記事